The role of microglia during life span in neuropsychiatric disease - an animal study

Schizophrenia Research

Volumn 143, Issue 1, 2013, Pages 221-222

  Manitz, Marie Pierre ^a   Esslinger, Manuela ^a   Wachholz, Simone ^a   Plümper, Jennifer ^a   Friebe, Astrid ^a   Juckel, Georg ^a   Wolf, Rainer ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BAGG ALBINO MOUSE; BRAIN REGION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; FRONTAL CORTEX; IMMUNOHISTOCHEMISTRY; LETTER; MICROGLIA; MOUSE; NONHUMAN; PRENATAL EXPOSURE; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SAMPLE SIZE; SCHIZOPHRENIA; SECONDARY VISUAL CORTEX; TISSUE SECTION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BRAIN; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; MALE; MENTAL DISORDERS; MICE; MICE, INBRED BALB C; MICROFILAMENT PROTEINS; MICROGLIA; POLYDEOXYRIBONUCLEOTIDES; STATISTICS, NONPARAMETRIC;

EID: 84871935456     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.10.028     Document Type: Letter

References (11)

1. Fields R.D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 2008, 31:361-370.
2. Howes O.D., Fusar-Poli P., Bloomfield M., Selvaraj S., McGuire P. From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments. Curr. Pharm. Des. 2012, 18:459-465.
3. Juckel G., Manitz M.P., Brune M., Friebe A., Heneka M.T., Wolf R.J. Microglial activation in a neuroinflammational animal model of schizophrenia-a pilot study. Schizophr. Res. 2011, 131:96-100.
4. Meyer U., Feldon J. Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav. Brain Res. 2009, 204:322-334.
5. Muller N., Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998, 22:1-33.
6. Muller N., Schwarz M.J., Dehning S., Douhe A., Cerovecki A., Goldstein-Muller B., Spellmann I., Hetzel G., Maino K., Kleindienst N., Moller H.J., Arolt V., Riedel M. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 2006, 11:680-684.
7. Paxinos G., Franklin K.B.J. Mouse brain in stereotaxic coordinates 2001, 2nd, Academic Press, New York.
8. Radewicz K., Garey L.J., Gentleman S.M., Reynolds R. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 2000, 59:137-150.
9. Strous R.D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J. Autoimmun. 2006, 27:71-80.
10. van Berckel B.N., Bossong M.G., Boellaard R., Kloet R., Schuitemaker A., Caspers E., Luurtsema G., Windhorst A.D., Cahn W., Lammertsma A.A., Kahn R.S. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 2008, 64:820-822.
11. Winter C., Djodari-Irani A., Sohr R., Morgenstern R., Feldon J., Juckel G., Meyer U. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int. J. Neuropsychopharmacol. 2009, 12:513-524.